Insiders · Profile

WILLIAMS DOUGLAS E

Director at Ovid Therapeutics · EVP Research & Development at Biogen. Filing since 26 Aug 2013. CIK 0001184847

Company

Date

Role

Action

Amount

Of holding

14 Aug 2018

Director

Bought

5,000

$32.44K

opened

19 Jun 2015

EVP Research & Development

Sold, plan not stated

3,841

$1.57M

24.5%

19 Mar 2014

EVP Research & Development

Sold, plan not stated

3,505

$1.23M

30.5%

26 Aug 2013

EVP Research & Development

Sold, plan not stated

4,368

$923.17K

48.9%

4 decisions on file.